Published in Biol Psychol on February 17, 2010
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens (2005) 1.61
Improvement of ultrasonic myocardial properties after aortic valve replacement for pure severe aortic stenosis: the predictive value of ultrasonic tissue characterization for left ventricle reverse remodeling. J Am Soc Echocardiogr (2010) 1.41
Heart rate and double product in relation to insulin resistance in patients with hypertension and coronary artery disease. Kardiol Pol (2013) 1.39
Association between the Pl(A) platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease. Int J Cardiol (2003) 1.39
Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization. J Am Coll Cardiol (2010) 1.20
Ventricular rupture in Takotsubo cardiomyopathy. Eur Heart J (2012) 1.01
Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J (2003) 0.97
Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease. J Am Soc Echocardiogr (2006) 0.93
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension. Fundam Clin Pharmacol (2011) 0.90
Prognostic value of the six-minute walk test in heart failure patients undergoing cardiac surgery: a literature review. Rehabil Res Pract (2013) 0.88
Management of left ventricular diastolic heart failure: is it only blood pressure control? Curr Opin Cardiol (2009) 0.86
[Polish forum for prevention guidelines on cardiovascular risk assessment]. Kardiol Pol (2007) 0.84
Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Eur Heart J (2010) 0.82
Aging in autonomic control by multifractal studies of cardiac interbeat intervals in the VLF band. Physiol Meas (2011) 0.81
[Review of epidemiologic studies in cardiology in Poland]. Kardiol Pol (2006) 0.81
Exercise stress test and comparison of ST change with cardiac nucleotide catabolite production in patients with coronary artery disease. Cardiol J (2007) 0.81
Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation-The POWER Survey. Int J Hypertens (2013) 0.79
[Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome) (2007) 0.79
Incidental diagnosis of unicuspid aortic valve in an asymptomatic adult. Kardiol Pol (2013) 0.77
Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. J Appl Genet (2012) 0.77
Polish Forum for Prevention Guidelines on cardiovascular diseases prevention in children and adolescents. Kardiol Pol (2010) 0.77
Recanalization of isolated chronic total occlusions in patients with stable angina. Int J Cardiol (2012) 0.77
Autologous transplantation of bone marrow stem cells prepared by the point-of-care system in a patient with myocardial ischemia due to coronary artery chronic total occlusion. Int J Cardiol (2013) 0.77
Noninvasive assessment of endothelial function and vascular parameters in patients with familial and nonfamilial hypercholesterolemia. Pol Arch Med Wewn (2014) 0.76
Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease. Clin Chem Lab Med (2003) 0.76
Comparison of wavelet transform modulus maxima and multifractal detrended fluctuation analysis of heart rate in patients with systolic dysfunction of left ventricle. Ann Noninvasive Electrocardiol (2008) 0.76
[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol (2015) 0.76
Polish Forum for Prevention: a response to the European Society of Cardiology 'call for action' in Poland. Eur J Cardiovasc Prev Rehabil (2010) 0.75
[Where are we in treatment of stable coronary disease--commentary on treatment RECENT]. Kardiol Pol (2009) 0.75
Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure - data from a large single-centre cohort. Kardiol Pol (2016) 0.75
[Ventricular septal rupture complicating surgically treated left ventricular free wall rupture in a patient with acute myocardial infarction. A case report]. Kardiol Pol (2006) 0.75
[Giant cell arteritis involving the aorta and pulmonary trunk]. Kardiol Pol (2013) 0.75
Takotsubo cardiomyopathy related to compound electrolyte aberration and anemia in Crohn's disease. Int J Cardiol (2011) 0.75
Effectiveness of hypertension treatment assessed by blood pressure level achieved in primary care setting in Poland. Blood Press (2003) 0.75
[Magnetic resonance imaging in a patient with an implantable cardioverter-defibrillator]. Kardiol Pol (2013) 0.75
Sympathetic neural responses to coronary occlusion during balloon angioplasty. J Hypertens (2007) 0.75
Contemporary trans-catheter treatment of severe aortic stenosis. Kardiol Pol (2011) 0.75
An interventional percutaneous approach of posttraumatic left coronary artery fistula repair. J Invasive Cardiol (2012) 0.75
The successful treatment of cardiogenic shock with primary percutaneous coronary intervention (T-stenting) of total occluded unprotected left main performed during cardiopulmonary resuscitation. Kardiol Pol (2015) 0.75
[Severe hypercholesterolaemia - when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement]. Kardiol Pol (2016) 0.75
Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry. J Invasive Cardiol (2013) 0.75
[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach]. Psychiatr Pol (2014) 0.75
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy]. Kardiol Pol (2012) 0.75
Experimental hyperlipidaemia does not prevent preconditioning and it reduces ischemia-induced apoptosis. Int J Cardiol (2007) 0.75
Complexity of the heart rhythm after heart transplantation by entropy of transition network for RR-increments of RR time intervals between heartbeats. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
Polish Forum for Prevention of Cardiovascular Diseases Guidelines on prophylactic pharmacotherapy. Kardiol Pol (2011) 0.75
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design. Vnitr Lek (2017) 0.75
Polish Forum for Prevention Guidelines for screening procedures for cardiovascular diseases. Kardiol Pol (2011) 0.75
Early-generation versus new-generation drug-eluting stents in isolated chronic total occlusion: on the road to extinction? J Invasive Cardiol (2014) 0.75
[Catastrophic antiphospholipid syndrome complicated by cardiogenic shock - a case report]. Kardiol Pol (2009) 0.75
Acute coronary artery thrombosis during the postpartum period complicated by cardiogenic shock and AH1N1 infection. Kardiol Pol (2012) 0.75
Joint position statement of the Polish Cardiologic Society, the Polish Gynaecological Society and the Polish Menopause and Andropause Society on the effect of postmenopausal hormone replacement therapy on the cardiovascular system. Gynecol Endocrinol (2008) 0.75
Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Pol Arch Med Wewn (2013) 0.75
[Periodontal and dental state of patients with coronary heart disease]. Przegl Lek (2004) 0.75
[Availability of coronarography based on the examinations performed in the Haemodynamic Laboratory of the Medical University of Gdansk]. Wiad Lek (2002) 0.75
Polish forum for prevention guidelines on metabolic syndrome. Kardiol Pol (2010) 0.75
Successful recanalisation of isolated chronic total occlusions improves outcomes in long-term observation: a case-control study. Kardiol Pol (2013) 0.75
RUN/EDIT information processing mode and phasic cardiac acceleration. Psychophysiology (2008) 0.75
The disk of bileaflet mechanical mitral valve prosthesis jammed by ruptured papillary muscle. J Thorac Cardiovasc Surg (2006) 0.75
[Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system]. Kardiol Pol (2009) 0.75
Program running versus problem solving: two patterns of cardiac response. Int J Psychophysiol (2012) 0.75
Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression. Cardiol J (2017) 0.75
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology. Vnitr Lek (2017) 0.75
[Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum]. Kardiol Pol (2013) 0.75
Implantation of nitinol self-expanding carotid stent to release circumflex artery compression caused by mitral valve prosthesis. Eur Heart J (2011) 0.75
Triple occurrence of Takotsubo cardiomyopathy. Kardiol Pol (2013) 0.75
Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases. Kardiol Pol (2007) 0.75
Cerivastatin and hypercholesterolemia reduce apoptosis of cardiomyocytes in guinea pig papillary muscle subjected to hypoxia/reoxygenation. Pharmacol Rep (2006) 0.75
[Transcatheter aortic valve implantation for degeneration of biological aortic prosthesis]. Kardiol Pol (2012) 0.75
Assessment of Subclinical Atherosclerosis Using Computed Tomography Calcium Scores in Patients with Familial and Nonfamilial Hypercholesterolemia. J Atheroscler Thromb (2015) 0.75
[Cardiologic health care in Poland--report from cardiology consultants in the year 2005]. Kardiol Pol (2005) 0.75
The Polish MacNew heart disease heath-related quality of life questionnaire: A validation study. Cardiol J (2015) 0.75